Antivirals: Achilles heel of Ebola viral entry

@article{Flemming2011AntiviralsAH,
  title={Antivirals: Achilles heel of Ebola viral entry},
  author={Alexandra Flemming},
  journal={Nature Reviews Drug Discovery},
  year={2011},
  volume={10},
  pages={731-731}
}

Topics from this paper

THE STRENGTHS, WEAKNESSES, OPPORTUNITIES, AND THREATS (SWOTs) ANALYSES OF THE EBOLA VIRUS – PAPER RETRACTED
  • M. Babalola
  • Biology, Medicine
  • African journal of infectious diseases
  • 2016
TLDR
The SWOT concept was adopted to elucidate the biological Strengths, Weaknesses, Opportunities, and Threats to Ebola virus as a pathogen with a view to understanding and devising holistic strategies at combating and overcoming the scourge of EVD. Expand
Resources, Guidance, Control and Prevention for Ebola Virus Disease- An Overview
Since the current Ebola Virus Disease (also referred to as Ebola Haemorrhagic Fever) outbreak began in Guinea in December of 2013, the outbreak now involves trans-mission in Guinea, Liberia, Nigeria,Expand
Болезнь, вызываемая вирусом ЭБола: от теории к пр актике
Резюме. В представленной статье обобщены результаты последних эпидемиологических, клинических, вирусологических исследований, направленных на изучение инфекции, вызванной вирусом Эбола. ОсобоеExpand
A Review on Ebola Virus Disease
TLDR
The Ebola virus seems to have enthralled the global interest due to its lethal prospective, and the research is ongoing on development of making vaccine to curb this virus yet licensed success or specific treatment is not achieved. Expand
Pathogenesis of Ebola virus: A deadly virion hosted by bats
TLDR
Ebola Virus Infection is a rare but deadly virus that causes bleeding inside and outside the body, as well as from the eyes, ears, and nose, and it spreads to people by contact with the skin or bodily fluids of an infected animal. Expand
Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives.
TLDR
The scope of this article is to briefly review the most promising therapeutics for EHF, based on the data coming from rare clinical reports, studies on animals and results from in vitro models. Expand
Targeting host factors to circumvent anti-malarial drug resistance.
TLDR
Recent progress in host target-based anti-viral and anti-bacterial approaches are highlighted and possible host targets that may be used for anti-malarial interventions are discussed. Expand

References

SHOWING 1-4 OF 4 REFERENCES
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1
TLDR
It is shown that membrane fusion mediated by filovirus glycoproteins and viral escape from the vesicular compartment require the NPC1 protein, independent of its known function in cholesterol transport, which indicates potential antiviral strategies to combat these deadly agents. Expand
Are Government Bonds Net Wealth?
  • R. Barro
  • Economics
  • Journal of Political Economy
  • 1974
The assumption that government bonds are perceived as net wealth by the private sector is crucial in demonstrating real effects of shifts in the stock of public debt. In particular, the standardExpand